NAI Plus Standard of Care Compared With Placebo Plus Standard of Care in Critically Ill Adults With Sepsis
NCT07783789
Critical Illness, Disease Attributes
View Trial DetailsNCT Number: NCT07832890
This prospective cohort study aims to determine the incidence of sepsis-associated liver injury (SALI) among pediatric patients with sepsis admitted to Assiut University Children's Hospital and to evaluate its association with clinical outcomes.
Trial opening soon.
Get Notified1 month–18 year
All sexes
Observational
Sepsis-associated liver injury (SALI) is associated with poor prognosis in children with sepsis. This observational study will include children aged 1 month to 18 years diagnosed with sepsis according to the Phoenix Sepsis Score (≥2 points).
Patients will be monitored for the development of SALI, defined as ALT ≥2 times the age-specific upper limit of normal and/or total bilirubin >2 mg/dL in the absence of another identifiable cause of liver injury. Clinical outcomes including mortality, PICU admission, length of stay, and need for organ support will be recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days after hospital admission
Proportion of children with sepsis who develop SALI defined as total bilirubin greater than or equal to 4.0 mg per dL or ALT greater than 2 times age-specific upper limit of normal during hospitalization. Calculated as number of SALI cases divided by total number of enrolled sepsis patients
Time frame: 30 days after hospital admission
Number of participants who die from any cause during hospital stay comparing SALI group versus non-SALI group. Mortality includes 28-day and in-hospital mortality
Time frame: 30 days after hospital admission
Number of participants requiring admission to pediatric intensive care unit PICU among SALI and non-SALI groups
Time frame: 30 days after hospital admission
Length of PICU stay measured in days from PICU admission to PICU discharge or death among those admitted to PICU
Time frame: 30 days after hospital admission
Total duration of hospital stay measured in days from hospital admission to discharge or death
Time frame: 30 days after hospital admission
Number of participants requiring invasive mechanical ventilation during hospitalization in SALI versus non-SALI groups
Time frame: 30 days after hospital admission
Number of participants requiring vasopressor or inotropic support for septic shock management
Time frame: 30 days after hospital admission
Number of participants developing acute kidney injury AKI and multiple organ dysfunction syndrome MODS during hospitalization according to standard criteria
Trial opening soon.
Get NotifiedAssiut University
Other
Sepsis Associated Liver Injury in Pediatric Patients at Assiut University Children's Hospital: Incidence, Predictors and Clinical Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07783789
Critical Illness, Disease Attributes
View Trial DetailsNCT07670299
Critical Illness, Disease Attributes
View Trial DetailsNCT07667153
Infections, Inflammation
View Trial DetailsNCT07184593
Acute Brain Injury, Brain Diseases
View Trial Details